期刊文献+

慢性乙型肝炎患者外周血cd8+t细胞tim-3表达及意义 被引量:1

expression of tim-3 in peripheral cd8 + t cells and its significance in patients with chronic hepatitis b
原文传递
导出
摘要 目的 分析慢性乙型肝炎(chb)患者外周血单个核细胞(pbmc)中cd8+t细胞免疫球蛋白和黏蛋白结构域分子-3(tim-3)的表达及其意义.方法 用流式细胞术检测58例chb患者和16名健康体检者pbmc中cd8+t细胞tim-3的表达水平.采用酶联免疫斑点试验(elispot)检测tim-3单克隆抗体阻断tim-3/tim-3l通路前后hla-a2阳性患者pbmc中产生ifnγ的hbv特异性细胞毒性t淋巴细胞(ctl)数量的改变.阻断前后斑点数量的比较采用配对t检验,定量资料用spearman非参数检验进行相关性分析.结果 chb患者pbmc中cd8+t淋巴细胞tim-3分子表达水平为(14.2±8.98)%,明显高于健康体检者的(4.80±2.92)%,差异有统计学意义(x2=92.48,p<0.05).16例重度chb患者和42例轻度chb患者cd8+t细胞tim-3表达分别为( 19.54±10.95)%和(9.58±7.30)%,差异有统计学意义(x2=77.24,p<0.05).tim-3单克隆抗体阻断tim-3通路前,chb患者pbmc中产生ifnγ的hbv特异性ctl数量为7.27 ±3.14,阻断后为19.62 ±4.97,差异有统计学意义(t=2.95,p <0.05).结论 chb患者pbmc中cd8+t细胞高表达tim-3分子抑制了hbv特异性ctl功能,阻断tim-3通路可以促进表达ifnγ的hbv特异性ctl增殖,增强抗病毒效应. objective to investigate the expression of t cell immunoglobulin-and mucin-domaincontaining molecule-3 (tim-3) in peripheral cd8 +t cells and its significance in patients with chronic hepatitis b (chb).methods fifty-eight chb patients and 16 healthy controls were enrolled.tim-3 expression in cds + t cells was detected by flow cytometry,and quantities of ifnγ-producing hbv-specific cytotoxic t lymphocytes (ctls) in hla-a2 positive subjects were detected by enzyme-linked immunosorbent spot (elispot) test before and after the blockade of tim-3/tim-3l pathway.paired t test was performed to compare the quantities of ctls before and after the blockade,and nonparametric spearman correlation analysis was performed to explore the correlation in quantitive data.results tim-3 expression in chb patients was (14.2 ± 8.98 )%,which was higher than that of healthy controls (4.80 ± 2.92)%,and the difference was of statistical significance (x2 =92.48,p < 0.05 ) tim-3 expressions in 16 severe chb patients and 42 mild chb patients were ( 19.54 ± 10.95) % and (9.58 ± 7.30) %,respectively,and the difference was statistically significant (x2 =77.24,p < 0.05 ). before the blockade of tim-3/tim-3l pathway,ifnγ-producing hbv-specific ctls were 7.27 ± 3.14,and it increased to 19.62 ± 4.97 after the blockade ( t =2.95,p < 0.05 ).conclusion the upregulation of tim-3 on peripheral cd8 + t cells may inhibit hbv-specific ctls,and the blockade of tim-3 pathway can enhance the proliferation of ifnγ-producing hbv-specific ctls,thus can enhance antiviral effect.
出处 《中华临床感染病杂志》 CAS 2012年第1期33-36,23,后插1-后插2,共4页 Chinese Journal of Clinical Infectious Diseases
  • 相关文献

参考文献12

  • 1Klenermau P,Hill A. T cells and viral persistence:lessons from diverse infections[J].Nature Immunology,2005,(09):873-879.
  • 2Soemohardjo S. New option in the treatment of chronic hepatitis[J].Advances in Experimental Medicine and Biology,2003.191-198.
  • 3Barber DL,Wherry E J,Masopust D. Restoring function in exhausted CD8 T cells during chronic viral infection[J].Nature,2006,(7077):682-687.
  • 4Day CL,Kaufmann DE,Kiepiela P. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression[J].Nature,2006,(7109):350-354.
  • 5Petrovas C,Casazza JP,Brenchley JM. PD-1 is a regulator of virus-specific CD8 + T cell survival in HIV infection[J].Journal of Experimental Medicine,2006,(10):2281-2292.
  • 6Trautmann L,Janbazian L,Chomont N. Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction[J].Nature Medicine,2006,(10):1198-1202.
  • 7D′Souza M,Fontenot AP,Mack DG. Programmed death 1 expression on HIV-specific CD4 + T cells is driven by viral replication and associated with T cell dysfunction[J].Journal of Immunology,2007,(03):1979-1987.
  • 8Golden-Mason L,Palmer BE,Kassam N. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4 + and CD8 +T cells[J].Journal of Virology,2009,(18):9122-9130.
  • 9中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14013
  • 10Rodriguez-Manzanet R,DeKruyff R,Kuchroo VK. The costimulatory role of TIM molecules[J].Immunological Reviews,2009,(01):259-270.

共引文献14012

同被引文献21

  • 1李鸿宾,江晓萍,叶珺,黄浏培.测定慢性乙型肝炎患者外周血T淋巴细胞亚群的临床意义[J].安徽医药,2006,10(8):588-589. 被引量:30
  • 2Kao JH, Chen DS. Global control of hepatitis B virus infection [ J]. Lancet Infect Dis,2002,2 : 395-403.
  • 3Sun Z, Ming L, Zhu X, et al. Prevention and control of hepatitis B in China[ J]. J Med Virol,2002, 67:447-450.
  • 4Wursthorn K, Wedemeyer H, Manns MP. Managing HBV in patients with impaired immunity[ J]. Gut, 2010, 59 : 1430-1445.
  • 5Rehermann B. Intrahepatic T cells in hepatitis B: viral control versus liver cell injury[ J]. J Exp Meal,2000,191 : 1263-1268.
  • 6Hu S J, Xing JL. An experimental model for chronic compression of dosal root ganglion produced by intervertebral foramen stenosis in rat[J]. Pain, 1998, 77:15-23.
  • 7中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年)[J].中华l临床感染病杂志,2011,4:1-13.
  • 8Xanthou G, Polihronis M, Tzioufas AG, et al. " Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sj6gren'ssyndrome patients: possible participation in lymphoid structure formation[ J] Arthritis Rheum, 2001, 44:408-418.
  • 9Djukanovic R. The role of costimulation in airway inflammation [J]. Clin Exp Allergy,2000, 30 Suppl 1 : 146-150.
  • 10Keir ME, Sharpe AH. The B7/CD28 costimulatory family in autoimmunity[J]. Immunol Rev, 2005,204: 128-143.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部